Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Shares Issued (2019 - 2025)

aTYR PHARMA's Shares Issued history spans 5 years, with the latest figure at $17000.0 for Q2 2025.

  • For Q2 2025, Shares Issued changed N/A year-over-year to $17000.0; the TTM value through Dec 2025 reached $19000.0, changed N/A, while the annual FY2025 figure was $19000.0, N/A changed from the prior year.
  • Shares Issued reached $17000.0 in Q2 2025 per ATYR's latest filing, up from $2000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $6.4 million in Q1 2021 to a low of -$15.2 million in Q2 2021.
  • Average Shares Issued over 3 years is -$1.1 million, with a median of $10000.0 recorded in 2021.
  • The largest YoY upside for Shares Issued was 113.33% in 2021 against a maximum downside of 424.1% in 2021.
  • A 3-year view of Shares Issued shows it stood at $3000.0 in 2021, then plummeted by 50066.67% to -$1.5 million in 2022, then surged by 101.13% to $17000.0 in 2025.
  • Per Business Quant, the three most recent readings for ATYR's Shares Issued are $17000.0 (Q2 2025), $2000.0 (Q1 2025), and -$1.5 million (Q2 2022).